Abstract
It is worth stating that a generation is needed to bring about a new family of drugs. After the deciphering of the genetic cause in 1995, two innovative classes of therapeutics are now available for spinal muscular atrophy (SMA): the repeated administration of antisens oligonucleotides and the one-shot administration of a scAAV9-SMN as a gene therapy. By addressing the genetic mechanisms of the disease, these drugs fundamentally change its course. These major advances in an extremely severe disease, often fatal before the age of 18 months in the type 1 form (50% of patients), pave the way for the treatment of other serious pathologies of the nervous or neuromuscular system, and provide unambiguous evidence of the effectiveness of these new classes of drugs called to address a number of genetic or acquired diseases. These breakthroughs raise also new scientific and technological questions (limited production yields of gene therapy drugs) but also ethical issues (access of patients to these innovative therapies) that resonate beyond this disease alone.
References
Oct 29, 1992·Nature·J WeissenbachM Lathrop
Jan 13, 1995·Cell·S LefebvreM Zeviani
Dec 16, 1993·Nature·D CohenJ Weissenbach
Jul 27, 2001·Fundamental & Clinical Pharmacology·S Guettier-SigristP Poindron
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Dec 2, 2010·Human Molecular Genetics·Elisa DominguezMartine Barkats
Nov 6, 2013·Proceedings of the National Academy of Sciences of the United States of America·Zhenxi ZhangGideon Dreyfuss
Dec 13, 2016·Lancet·Richard S FinkelKathie M Bishop
Apr 13, 2017·Translational Neuroscience·Eric W Ottesen
Aug 5, 2017·Disease Models & Mechanisms·Melissa BowermanUNKNOWN UK SMA Research Consortium
Dec 7, 2018·Pharmacology Research & Perspectives·Agnès PoirierLutz Mueller
Apr 26, 2019·Neurology·Basil T DarrasUNKNOWN ISIS-396443-CS2/ISIS-396443-CS12 Study Groups
Sep 19, 2019·European Journal of Human Genetics : EJHG·Stéphanie Nguengang WakapAna Rath
Oct 22, 2019·Therapeutics and Clinical Risk Management·Tamara Dangouloff, Laurent Servais
Mar 5, 2020·Médecine sciences : M/S·Martine Barkats